Ana González-Ortega

The NK-1 receptor is expressed in human melanoma and is involved in the antitumor action of the NK-1 receptor antagonist aprepitant on melanoma cell lines

Miguel Muñoz, Marisa Rosso, María José Robles‐Frías et al. · Laboratory Investigation · 2010 · 99 citations · Full text

Melanoma Cell Lines, Nk-1 Receptor, Human Melanoma +8

The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer

Miguel Muñoz, Ana González-Ortega, Manuel Vicente Salinas-Martín et al. · International Journal of Oncology · 2014 · 83 citations · Full text

Breast Oncology, Oncology, Medicine +15

The substance P/neurokinin-1 receptor system in lung cancer: Focus on the antitumor action of neurokinin-1 receptor antagonists

Miguel Muñoz, Ana González-Ortega, Marisa Rosso et al. · Peptides · 2012 · 80 citations

Neurokinin-1 Receptor Antagonists, Medicine, Receptor (Biochemistry) +9

Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts

Miguel Muñoz, Michael Berger, Marisa Rosso et al. · International Journal of Oncology · 2013 · 63 citations · Full text

Antitumor Activity, Immunology, Pharmacotherapy +21

The NK-1 receptor is expressed in human leukemia and is involved in the antitumor action of aprepitant and other NK-1 receptor antagonists on acute lymphoblastic leukemia cell lines

Miguel Muñoz, Ana González-Ortega, Rafael Coveñas · Investigational New Drugs · 2010 · 48 citations

Hematological Malignancy, Human Leukemia, Nk-1 Receptor +8